Miracor Medical SA is a leading medical device company that specializes in developing innovative solutions for the treatment of severe heart diseases. Their primary focus is on creating clinically effective technologies that significantly improve the lives of patients suffering from cardiac diseases. One of their groundbreaking products is the PiCSO® (Pressure-controlled intermittent Coronary Sinus Occlusion) system, which is used as a first-line therapy during percutaneous coronary intervention (PCI) to positively change the course for Acute Myocardial Infarct (MI) patients.

Miracor Medical has received FDA IDE Approval for a pivotal study of the PiCSO® system, further showcasing their commitment to advancing cardiovascular care. With a team of dedicated professionals and a track record of successful innovations, Miracor Medical is at the forefront of revolutionizing treatment options for patients with severe heart diseases. For more information or to get in touch with Miracor Medical, visit their website or contact their office in Belgium